Search results
8 gru 2020 · The Oxford/AstraZeneca Covid vaccine is safe and effective, giving good protection, researchers have confirmed in The Lancet, external journal. Most in the study were younger than 55, but...
The Oxford–AstraZeneca COVID-19 vaccine plays an important role in the global vaccine rollout especially in resource-limited settings as it provides a cheaper alternative to the Pfizer/BioNTech and Moderna mRNA vaccines and does not require the same cold-chain management.
19 maj 2023 · Careful planning for the COVID-19 vaccination program requires comprehensive review studies to evaluate the efficacy and safety of the vaccines. This study aims to conduct a meta-analysis to assess the Effectiveness and Efficacy of COVID-19 vaccines, including AstraZeneca, Pfizer, Moderna, Bharat, and Johnson & Johnson.
10 gru 2020 · The Oxford/AstraZeneca vaccine this week became the first major COVID vaccine candidate to have efficacy results from phase 3 trials published in a peer-reviewed journal. The vaccine,...
Effective therapeutic interventions for the treatment and prevention of coronavirus disease 2019 (COVID-19) are urgently needed. A systematic review was conducted to identify clinical trials of pharmacological interventions for COVID-19 published between 1 December 2019 and 14 October 2020.
25 mar 2021 · AstraZeneca says it plans to file for emergency-use authorization for the vaccine from the US Food and Drug Administration (FDA), and to submit the analysis of the trial for peer review and...
23 lut 2022 · The first peer-reviewed clinical trial evidence that a Covid-19 vaccine provided robust protection against SARS-CoV-2 infection was published in the Journal in December 2020, 1 less than a...
